Skin Regeneration Using Dermal Substrates that Contain Autologous Cells and Silver Nanoparticles to Promote Antibacterial Activity: In Vitro Studies by Zieger, Michael A. J. et al.
 Pages: 14 
Words: 2847 
Tables: 0 
Figures: 6 
References: 31 
Contact: Zieger Email: mazieger@iupui.edu 
Phone: (317)278-6555 
Guarantor: Zieger 
SKIN REGENERATION USING DERMAL SUBSTRATES THAT CONTAIN 
AUTOLOGOUS CELLS AND SILVER NANOPARTICLES TO PROMOTE 
ANTIBACTERIAL ACTIVITY- IN VITRO STUDIES 
Michael A. J. Zieger, PhD1
Manuel Ochoa, MS2 
Rahim Rahimi, MS2 
Gonzalo Campana, MD1
Sunil Tholpady, MD PhD3
Babak Ziaie, PhD2
Rajiv Sood, MD4 
1 Department of Surgery, Indiana University School of Medicine, 980 West Walnut Street, C630, 
Indianapolis, IN 46202 
2 Department of Electrical and Computer Engineering, Purdue University, Birck Nanotechnology 
Center, 1205 W. State St., West Lafayette, IN 47907 
3 Department of Surgery, Indiana University School of Medicine, Riley Hospital for Children, 
705 Riley Hospital Dr., Rm 2514, Indianapolis, IN 46202 
4 Department of Surgery, Indiana University School of Medicine, Eskenazi Hospital, 720 
Eskenazi Ave., Indianapolis, IN 46202 
Keywords: silver, nanoparticles, wound healing, Integra, adipose stem cells, keratinocytes 
Presentations: Presented as a Poster Presentation at the Military Health System Research 
Symposium, Fort Lauderdale FL, August 17-20, 2015 
Funding: This work was internally funded 
Acknowledgments: None 
___________________________________________________________________
This is the author's manuscript of the article published in final edited form as:
Zieger, M. A., Ochoa, M., Rahimi, R., Campana, G., Tholpady, S., Ziaie, B., & Sood, R. (2017). Skin Regeneration Using Dermal Substrates 
that Contain Autologous Cells and Silver Nanoparticles to Promote Antibacterial Activity: In Vitro Studies. Military Medicine, 182.
http://dx.doi.org/10.7205/MILMED-D-16-00133
ABSTRACT 
We hypothesized that the addition of silver nanoparticles (AgNP) to a dermal substrate would 
impart anti-bacterial properties without inhibiting the proliferation of contained cells.  Our in 
vitro model was based upon the commercial substrate, Integra.  The substrate was prepared by 
simple immersion into 0-1% suspension of AgNP (75 or 200 nm-diam.) followed by rinsing for 
20 minutes and sterilization under a UV-C lamp.  A total of 107 human adipose stem cells/cm3 
were injected and after 1 hour, 6x105 keratinocytes/cm2 were seeded and cultured for up to 14 
days.  Constructs were evaluated using a metabolic assay (WST-1), H&E and immunoperoxidase 
staining.  Bactericidal activity was measured using a log reduction assay against bacteria that are 
prevalent in burns.  The presence of AgNP did not significantly change the metabolic activity of 
constructs after 14 days of culture and the distribution of cells within the substrate was 
unchanged from the controls that did not have AgNP.  Anti-bacterial activity of Integra® 
containing AgNP (75 nm-diam.) was concentration dependent.  In conclusion, the addition of 
AgNP to the dermal substrate suppressed bacterial growth but did not significantly affect cell 
proliferation, and may represent an important property to incorporate into a future clinical skin 
regeneration system.     
 
 
  
INTRODUCTION 
Up to 20% of combat casualties suffer significant burn injuries1.  The standard of care for deep 
burn wounds is skin grafting, with a piece of split-thickness skin taken from a healthy donor site.  
When burns cover a large area of the body, the area of healthy skin available for grafting is often 
insufficient.  Fortunately, skin can be harvested more than once from the same donor site 
because the epidermis regrows over time from proliferating keratinocytes that migrate from the 
hair follicles and sweat glands.  The dermis, however, cannot regrow, so skin grafts are taken 
with as little dermis as possible.  Acellular dermal matrices (ADM) have been developed for use 
with thin skin grafts to repair deep burn wounds.  ADMs are placed onto the freshly excised 
wounds and skin grafts are then applied on top two to three weeks later.  This time interval 
allows for migration of dermal cells into the matrix and generation of a vascular network before 
the application of the skin graft.  
A variation of the standard approach to repairing deep burn wounds could potentially accelerate 
healing and involves seeding the ADM with autologous cells at the time of its surgical placement 
onto the wound.  Mesenchymal stem cells (MSCs) derived from bone marrow or adipose tissues 
(ASCs) have been shown to accelerate wound healing by secreting trophic factors into the 
wound2, 3 or by differentiating into epidermal and dermal cells4-6.  Preclinical in vivo studies have 
shown that treating cutaneous wounds with ASCs increases new blood vessel formation7-9 and 
accelerates re-epithelialization8 and wound closure.10, 11  ASCs could be easily isolated from 
liposuction fat obtained from the patient at the time of the initial wound debridement surgery.  In 
addition to ASCs, the ADM could be seeded with autologous keratinocytes obtained by the 
enzymatic digestion of cutaneous punch biopsies.  This approach could potentially reconstitute 
the epidermis over the wound using isolated keratinocytes rather than split-thickness skin 
grafts12.  It would maximize the epidermal coverage derived from limited donor sites, avoid the 
morbidity associated with skin grafting and eliminate the delays in waiting for the regrowth of 
donor sites before additional skin graft harvesting.   
A major complication of deep burn wounds and large surface area wounds is the development of 
bacterial infections.13  Wound infections lead to delayed healing, longer hospital stays and higher 
mortality.14  Service members in particular have a higher rate of infection-associated mortality 
following combat-related burns because wound excision and skin grafting is often delayed until 
they are evacuated to a burn center.15  The current methods used to control bacterial wound 
infections involve the use of topical antimicrobial agents such as silver nitrate soaks, silver 
sulfadiazine cream and silver ion-release dressings, which demonstrate rapid and broad-spectrum 
anti-bacterial activity.16  Despite being clinically safe, silver anti-microbials are potentially 
cytotoxic, which may lead to impaired vascularization and epithelialization of the wound.  In the 
present pilot study, we investigated the potential of regenerating skin using dermal substrates that 
contain human ASCs, keratinocytes and silver nanoparticles (AgNP).  Integra wound 
regeneration matrix was treated with AgNP and the resulting anti-bacterial properties of the 
construct and the effect of the AgNP on ASC and keratinocyte proliferation was measured in 
vitro.   
  
MATERIALS AND METHODS 
Isolation and Culture of Human ASCs   
Human adipose stem cells were isolated from human adipose tissue samples obtained by 
liposuction.  Briefly, samples were digested in 0.1% (w/v) collagenase P (Roche Diagnostics, 
Indianapolis, IN) for 25 minutes at 37°C.  Cells were then freed by vigorous mixing and 
centrifuged at 300 xg for 5 minutes to separate the stromal vascular fraction (SVF) from the fat 
cells.  The SVF pellet was resuspended in growth medium (EGM-2MV; Lonza, Walkersville, 
MD), pipetted sequentially through 500, 297 and 70 µm-sized mesh and cultured in T-75 flasks 
at 37°C in an atmosphere of 5% CO2.  The growth medium was changed every 48 hours and 
cells were passaged when 80-90% confluent.  Cells were used for experiments between passages 
3 and 6. 
Isolation of Human Keratinocytes 
Human keratinocytes were isolated from discarded bits of split-thickness skin used in skin 
grafting.  The pieces (2-3 mm wide) were incubated overnight in 1 mg/ml Dipase II (PluriSTEM, 
EMD Millipore) at 4°C.  The epidermis was then separated from the dermis, minced and 
incubated in 0.25% trypsin-EDTA (Gibco; Grand Island, NY) for 15 minutes at 37°C.  The 
trypsin was neutralized with KGM-Gold medium (Lonza, Walkersville, MD) containing 10% 
fetal bovine serum.  The pieces were gently triturated, pipetted through a series of meshes (500, 
297 and 70 µm), resuspended in keratinocyte growth medium  (KGM + 1.4 mM CaCl2 + 10% 
fetal bovine serum17) and then used directly.     
Culture of ASC/Keratinocytes in Integra® 
Integra® wound matrix (Integra Life Sciences, Plainsboro, NJ) was cut into 8 mm-diameter discs 
using a cork bore and equilibrated with growth medium in a 48-well plate.  Proliferating ASCs 
were trypsinized, resuspended in growth medium and 5 x 105 cells per disc (50 µl of 107 cells/ml) 
were injected using a 25-gauge needle.  One hour was allowed for ASCs to attach to the matrix 
and then 3 x 105 freshly isolated keratinocytes (6 x 105 cells/cm2) were pipetted onto the surface.  
Each construct was cultured in 1 ml of keratinocyte growth medium at 37°C with a medium change 
every 48 h.  After 7 days, the constructs were transferred to the 12 mm inserts of a 12-well 
Transwell® plate (3.0 µm polycarbonate membrane; Costar®, Corning, NY) and cultured for an 
additional 7 days in the same medium.  Wells and inserts were filled with 0.8 and 0.4 ml of 
medium, respectively, to maintain an air-liquid interface at the surface of the constructs to promote 
keratinocyte differentiation.18 
Measuring Cell Proliferation in Integra® 
The proliferation of cells in the Integra® constructs was measured using the WST-1 assay 
(Roche, Indianapolis, IN).  Briefly, discs of Integra® were seeded with ASCs or keratinocytes 
and cultured as previously described.  The constructs were collected over time, washed with 
Hanks Balanced Salt Solution containing calcium and magnesium (HBSS) and then incubated in 
240 µl of the WST-1 reagent (1:10 dilution with HBSS) for 4 h at 37°C.  Duplicate absorbance 
readings of the reaction medium were made at a wavelength of 450 nm and were corrected with 
background absorbance readings and a reference wavelength of 630 nm using the equation 
(A450nm – A630nm)sample – (A450nm – A630nm)blank.  In some experiments, the Integra® discs were pre-
loaded with 0, 0.25, 0.5 or 1.0% AgNP (200 nm diameter), seeded with 107 ASC/cm3, cultured 
for 14 days at 37°C and then measured with the WST-1 reagent. 
Loading Integra with Silver Nanoparticles 
The AgNPs (75 or 200 nm; aqueous suspensions) were purchased from nanoComposix, (San 
Diego, CA).  The particles were re-suspended by vigorous vortexing for 1 minute immediately 
before use.  One cm2 pieces of Integra were inverted onto sterile gauze to remove free water and 
then immersed into the AgNP suspension for 1 minute.  Particles that remained unbound to the 
matrix were washed free by vortexing the samples in Dulbecco’s-Phosphate Buffered Saline for 
20 minutes.  Samples were then sterilized by exposure to a UV-C lamp and subsequently seeded 
with ASCs or used to measure bactericidal activity.     
Assessment of AgNP Deposition by Scanning Electron Microscopy 
Samples of Integra® (5 x 5 mm2) were equilibrated in de-ionized water and upon removal, the 
liquid in the matrix was wicked away using a laboratory wipe (Kimwipes).  Next, samples were 
immersed in a 0.5% solution of AgNP (200 nm-diam.) for 1 minute.  Excess AgNP solution was 
wicked away from the AgNP-loaded Integra sample and the sample was then allowed to dry 
completely at room temperature.  The Integra® was then imaged via scanning electron 
microscopy (SEM).  For comparison, a sample of Integra® without AgNP was also dried and 
imaged in the same fashion.  
Measuring Bactericidal Activity of Integra®-AgNP 
The log reduction assay was used to measure the ability of Integra® containing AgNP to kill 
bacteria.  Bacterial cultures of Staphylococcus aureus and Pseudomonas aeruginosa (ATCC 25923 
and 27853) were recovered from frozen stock by overnight growth in tryptic soy broth at 37°C and 
Klebsiella pneumoniae (ATCC 31488) was recovered by overnight growth in nutrient broth #3.  
Bacterial suspensions were diluted to an OD600nm of about 0.2 immediately before use.  Fifty 
microliters of inoculum was injected per cm2 of Integra-AgNP and incubated at 37°C for 30 min to 
24 h in a humidified atmosphere.  Controls consisted of using Integra without AgNP, 1 cm2 pieces 
of Acticoat® (Smith and Nephew), which is a silver-coated wound dressing, and 1 cm2 pieces of 
the Acticoat absorbant core (without the silver coating).  At the appropriate times, the surviving 
bacteria were recovered by immersing the samples into neutralizing solution (1:10 dilution of 
inoculum) containing 0.4% sodium thioglycolate and 1% TWEEN 20.  Samples were vortexed and 
serially diluted in PBS.  100 µl of each dilution was plated on Mueller Hinton II Agar and colonies 
were grown at 37°C for 24 h and then counted.  Log reductions were calculated as log10 
(CFU/ml)Integra – log10 (CFU/ml)Integra-AgNP.  Similarly, log reduction for Acticoat was calculated as 
log10 (CFU/ml)absorbant core – log10 (CFU/ml)Acticoat. 
Histology/Immunoperoxidase Staining 
Integra® constructs were washed two times in HBSS, embedded in Optimum Cutting 
Temperature compound (Tissue-Tek, Sakura-Finetek USA, Torrance CA) medium and flash-
frozen in liquid nitrogen.  Twenty micron thick sections were stained with hematoxylin and eosin 
(H&E) for light microscopy and 5 µm sections were processed using an immunoperoxidase stain 
against keratin AE1/AE3 by the Indiana University Health Immunohistochemical Lab.  
Statistics 
Linear regression analysis (Instat 3, Graphpad Software, La Jolla CA) was used to determine 
whether WST-1 absorbance of constructs containing ASC or keratinocytes increased with culture 
time to signify cell proliferation within the Integra matrix.   
 
  
RESULTS AND DISCUSSION 
Integra® Supports Adipose Stem Cell and Keratinocyte Proliferation  
WST-1 absorbance readings are a measure of the amount of WST-1 reagent that is reduced by 
cell metabolism and therefore reflects the number of viable cells that are present in the Integra® 
matrix.  The metabolic activity of constructs containing human ASC or keratinocytes increased 
over the time spent in culture (Figure 1).  The number of ASCs that were injected into the Integra 
was about two-times the number of keratinocytes that were seeded on the surface.  However, the 
finding that the absorbance readings were much higher for ASCs than for keratinocytes likely 
reflects a difference in plating efficiencies, which for freshly isolated keratinocytes on plastic is 
typically less than 5%.19  For fresh ASCs, the plating efficiency has been reported at about 
22%.20   
Constructs containing both ASC and keratinocytes were examined histologically after 14 days, 
with the final 7 days of growth occurring at the air-liquid interface.  The micrographs show that 
the ASCs were scattered throughout the matrix while the keratinocytes formed multiple layers at 
the surface (Figures 2A and 2B).  This matched the method of delivery used for each cell type, 
which was injecting a small volume of concentrated ASCs into the Integra versus pipetting a 
dilute suspension of keratinocytes onto its surface.  Although our usual culture medium for ASCs 
is endothelial growth medium, the constructs containing both ASCs and keratinocytes were 
cultured in keratinocyte growth medium to support the proliferation of keratinocytes, which we 
have found to be the more difficult.  The keratinocyte medium contained added serum and 
calcium to promote the differentiation of keratinocytes as previously reported.17  The 
micrographs show the presence of a dense surface layer that stained strongly for keratin, but it is 
not clear if this represents differentiated or cornified cells or if it is an effect of dehydration due 
to the proximity of the water-air interface.   
Integra® Retains AgNP Following Immersion 
Immersion of Integra® into a 0.5% (w/v) AgNP suspension changed the Integra® from colorless 
to a dark brown or black coloration (Figure 3).  Integra® is made of type I collagen and 
chondroitin 6-sulphate in a 92/8 ratio.21  Ninety-eight percent of Integra® by volume consists of 
fluid-filled pores that are 30-120 µm in diameter.  When some of this large volume of fluid is 
wicked out of the matrix, its subsequent immersion into the AgNP suspension causes rapid 
imbibition of the particles. Scanning electron microscopy shows that the short exposure time was 
sufficient for the uptake and adherence of the particles to the collagen matrix (Figures 3C-3E). 
Drobota et al. studied AgNP in collagen solutions and found that AgNP bind to collagen mainly 
through strong electrostatic interactions with the carboxylate (COO-) and amine (NH2+) groups 
of the collagen.22  Moreover, particle-induced changes in collagen secondary structure occurred, 
from α-helix to the more compact β-sheet.22  In the Integra®, the collagens are cross-liked by a 
gluteraldehyde treatment, which potentially prevents similar AgNP-induced changes to the 
collagen structure.   
Integra®-AgNP Demonstrates Antibacterial Activity 
Figure 4 shows logarithmic reductions in the number of bacterial colonies that followed exposure 
of bacteria to Integra-AgNP.  S. aureus and P. aeruginosa were injected into Integra® that was 
pretreated with a 1% (w/v) suspension of 200 nm-diameter AgNP and incubated for 2 hours.  
Log reductions were less than 1 (0.10 and 0.44, respectively) and corresponded to decreases in 
colony forming units of about 20% and 64%, respectively, when compared to Integra® that did 
not contain AgNP (Figure 4A).  K. pneumoniae exposure to Integra®-AgNP for 24 hours 
produced a log reduction of 0.33 or a decrease in colony forming units of 54%.  In comparison, a 
30 minute exposure of K. pneumoniae to Acticoat wound dressing resulted in a log reduction of 
3.1 (over a thousand-fold decrease) when compared to a similar exposure to the Acticoat 
absorbant core that lacked the nanocrystaline silver sheet.  Behm et al. exposed S. aureus, P. 
aeruginosa and K. pneumoniae to Acticoat for 30 minutes and measured reductions in colony-
forming units of 3.7-4.7 logs,16 which is comparable to our measurements using Acticoat.  Some 
Integra® was pretreated with 75 nm-diameter AgNP, injected with K. pneumoniae and incubated 
at 37°C for 24 hours.  Figure 4B shows that there was an increasing trend in log reduction as the 
AgNP concentration increased between 0.1 and 1.0%.  A reduction of 3 or more logs is 
considered bactericidal.16  Our Integra®-AgNP constructs, on the other hand, may be defined 
more appropriately as bacteriostatic.    
The antimicrobial activity of silver is due to its ionic form (Ag+) and has been attributed to 
several mechanisms, including the blocking of cellular respiration,23 binding to bacterial 
membranes to disrupt membrane function24 and binding to and condensing bacterial DNA to 
inhibit cell replication.25  AgNP are composed of metallic silver, which is neutral, and the 
associated antimicrobial activity has been attributed to its release of ionic silver.26  However, 
some studies have implicated the particles themselves as the source of these toxic effects.27, 28  
The activity of AgNP is inversely proportional to their diameter as the surface to volume ratio of 
the particles increases with decreasing radius, thereby increasing the release of Ag+ ions.  In our 
studies, the log reduction following exposure to 75 nm diameter AgNP was about 2 times that of 
the 200 nm-diam. particles (0.66 vs. 0.33 CFU/ml; Figure 4).  
 
 
Integra®-AgNP Does Not Affect ASC Proliferation 
Integra® samples were preloaded with 200 nm-diameter AgNP.  Unattached particles that filled 
the pores of the matrix were washed out by vortexing the samples in D-PBS.  Samples were then 
injected with 107/cm3 ASC and cultured in EGM-2MV for 14 days.  The metabolic activity of 
the constructs was measured using the WST-1 assay.  The absorbance readings were not 
significantly different when the Integra® was preloaded with 0, 0.25, 0.5 or 1% AgNP (Figure 5), 
hence cell proliferation was not affected by the use of up to 1% (w/v) AgNP.  The H&E staining 
of the constructs after 14 days shows that ASCs were attached to the matrix and evenly 
distributed throughout for all concentrations of AgNP (Figure 6).  No AgNP or AgNP aggregates 
were present in the pores and demonstrates that the wash-out step was effective.  However, the 
eosine staining of the collagen is slightly darker or appears to have a slight “dusty” appearance in 
samples that were treated with 1% AgNP (Figure 6D). The wash-out step eliminated a significant 
source of toxicity (data not shown) and therefore is an important part of the sample preparation.   
 
Cytotoxicity generally correlates with silver dissociation.29  Le Duc et al. measured the effect of 
topical antiseptics on human skin substitutes in vitro and found that Acticoat decreased 
metabolic activity to about 60% of untreated control samples.30  However, decreases in 
metabolic activity due to the presence of AgNP did not equate with a loss of cell viability in vitro 
and did not inhibit wound healing,31 despite the fact that aggregates of AgNP became localized 
in the cytoplasm of dermal fibroblasts of healed wounds.31  The implications of these reports and 
our findings are that higher concentrations of AgNP in Integra® and increased anti-bacterial 
activity may be achievable before metabolic suppression, loss of cell viability and impairment of 
wound healing are likely to occur. 
CONCLUSIONS 
Integra® wound matrix was made bacteriostatic by the addition of silver nanoparticles.  The new 
antibacterial properties did not affect the proliferation of ASCs or keratinocytes that were 
cultured in the matrix.  An expanded study of these properties at higher AgNP concentrations 
and their effects on oxidative stress, inflammation, vascularization and epithelialization of 
wounds is expected to further enhance the performance of this matrix and increase its potential 
utility in current and future treatments of deep burn injuries.     
  
  
  

  

  
REFERENCES 
1. Kauvar DS, Wolf SE, Wade CE, Cancio LC, Renz EM, Holcomb JB. Burns sustained in combat 
explosions in Operations Iraqi and Enduring Freedom (OIF/OEF explosion burns). Burns. 2006;32(7):853-
7. 
2. Hu LI, Zhao J, Liu J, Gong N, Chen L. Effects of adipose stem cell-conditioned medium on the 
migration of vascular endothelial cells, fibroblasts and keratinocytes. Experimental and Therapeutic 
Medicine. 2013;5(3):701-6. 
3. Lee SH, Jin SY, Song JS, Seo KK, Cho KH. Paracrine Effects of Adipose-Derived Stem Cells on 
Keratinocytes and Dermal Fibroblasts. Ann Dermatol. 2012;24(2):136-43. 
4. Seo BF, Kim KJ, Kim MK, Rhie JW. The effects of human keratinocyte coculture on human 
adipose-derived stem cells. International Wound Journal. 2014:n/a-n/a. 
5. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited 
into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. 
Journal of immunology (Baltimore, Md : 1950). 2008;180(4):2581-7. 
6. Chavez-Munoz C, Nguyen KT, Xu W, Hong SJ, Mustoe TA, Galiano RD. Transdifferentiation of 
adipose-derived stem cells into keratinocyte-like cells: engineering a stratified epidermis. PLoS One. 
2013;8(12):e80587. 
7. Komatsu I, Yang J, Zhang Y, Levin LS, Erdmann D, Klitzman B, et al. Interstitial engraftment of 
adipose-derived stem cells into an acellular dermal matrix results in improved inward angiogenesis and 
tissue incorporation. Bournal of Biomedical Materials Research Part A. 2013;101A:2939-47. 
8. Huang SP, Hsu CC, Chang SC, Wang CH, Deng SC, Dai NT, et al. Adipose-derived stem cells 
seeded on acellular dermal matrix grafts enhance wound healing in a murine model of a full-thickness 
defect. Annals of Plastic Surgery. 2012;69(6):656-62. 
9. Orbay H, Takami Y, Hyakusoku H, Mizuno H. Acellular dermal matrix seeded with adipose-
derived stem cells as a subcutaneous implant. Aesthetic Plast Surg. 2011;35(5):756-63. 
10. Altman AM, Matthias N, Yan Y, Song YH, Bai X, Chiu ES, et al. Dermal matrix as a carrier for in 
vivo delivery of human adipose-derived stem cells. Biomaterials. 2008;29(10):1431-42. 
11. Hadad I, Johnstone BH, Brabham JG, Blanton MW, Rogers PI, Fellers C, et al. Development of a 
porcine delayed wound-healing model and its use in testing a novel cell-based therapy. Int J Radiat 
Oncol Biol Phys. 2010;78(3):888-96. 
12. Gravante G, Di Fede MC, Araco A, Grimaldi M, De Angelis B, Arpino A, et al. A randomized trial 
comparing ReCell® system of epidermal cells delivery versus classic skin grafts for the treatment of deep 
partial thickness burns. Burns. 2007;33(8):966-72. 
13. Rafla K, Tredget EE. Infection control in the burn unit. Burns. 2011;37(1):5-15. 
14. Shupp JW, Pavlovich AR, Jeng JC, Pezzullo JC, Oetgen WJ, Jaskille AD, et al. Epidemiology of 
bloodstream infections in burn-injured patients: a review of the national burn repository. Journal of 
burn care & research : official publication of the American Burn Association. 2010;31(4):521-8. 
15. Keen Iii EF, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al. Incidence and 
bacteriology of burn infections at a military burn center. Burns. 2010;36(4):461-8. 
16. Gallant-Behm CL, Yin HQ, Liu S, Heggers JP, Langford RE, Olson ME, et al. Comparison of in vitro 
disc diffusion and time kill-kinetic assays for the evaluation of antimicrobial wound dressing efficacy. 
Wound Repair and Regeneration. 2005;13(4):412-21. 
17. Lamb R, Ambler CA. Keratinocytes propagated in serum-free, feeder-free culture conditions fail 
to form stratified epidermis in a reconstituted skin model. PLoS One. 2013;8(1):e52494. 
18. Asselineau D, Bernhard B, Bailly C, Darmon M. Epidermal morphogenesis and induction of the 67 
kD keratin polypeptide by culture of human keratinocytes at the liquid-air interface. Experimental cell 
research. 1985;159(2):536-9. 
19. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the 
formation of keratinizing colonies from single cells. Cell. 1975;6(3):331-43. 
20. Choudhery MS, Badowski M, Muise A, Pierce J, Harris DT. Cryopreservation of whole adipose 
tissue for future use in regenerative medicine. Journal of Surgical Research. 2014;187(1):24-35. 
21. Sciences IL. 
22. Drobota M, Grierosu I, Radu I, Vasilescu DS. The effect of silver nanoparticles on the collagen 
secondary structure. Key Engineering Materials. 2015;638:8-13. 
23. Holt KB, Bard AJ. Interaction of silver(I) ions with the respiratory chain of Escherichia coli: an 
electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of 
micromolar Ag+. Biochemistry. 2005;44(39):13214-23. 
24. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as 
a model for Gram-negative bacteria. Journal of Colloid and Interface Science. 2004;275(1):177-82. 
25. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect 
of silver ions on Escherichia coli and Staphylococcus aureus. Journal of Biomedical Materials Research. 
2000;52(4):662-8. 
26. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H. Toxicity of silver nanoparticles—
Nanoparticle or silver ion? Toxicology Letters. 2012;208(3):286-92. 
27. Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, et al. Toxicity of silver 
nanoparticles to Chlamydomonas reinhardtii. Environmental science & technology. 2008;42(23):8959-
64. 
28. Kim S, Choi JE, Choi J, Chung K-H, Park K, Yi J, et al. Oxidative stress-dependent toxicity of silver 
nanoparticles in human hepatoma cells. Toxicology in Vitro. 2009;23(6):1076-84. 
29. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, et al. A comparative study of the 
cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound repair 
and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair 
Society. 2007;15(1):94-104. 
30. Duc Q, Breetveld M, Middelkoop E, Scheper RJ, Ulrich MM, Gibbs S. A cytotoxic analysis of 
antiseptic medication on skin substitutes and autograft. The British journal of dermatology. 
2007;157(1):33-40. 
31. Rigo C, Ferroni L, Tocco I, Roman M, Munivrana I, Gardin C, et al. Active silver nanoparticles for 
wound healing. Int J Mol Sci. 2013;14(3):4817-40. 
 
 
